Clinical Trial Update: TINN2: Treat Infection in NeoNates 2 [Phase 3]

View source ↗

Summary

A Phase 3 trial named TINN2 (Treat Infection in Neonates 2) investigating treatment for bronhopulmonary dysplasia in neonates has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Bronchopulmonary Dysplasia | Phase 3 | Status: WITHDRAWN